TipRanks
Go Ultimate55% OFF

Cosmax BTI Inc. (044820) AI Stock Analysis

KR:044820

Cosmax BTI Inc.

(Korea Exchange:044820)

Select Model
Rating:65Neutral
Price Target:KRW 24,349.00â–²(10.93% Upside)
Action:initiatedcoverage
Date:10/28/26

The score is driven primarily by improving operating performance (stronger growth and margin rebound) but held back by high leverage and weak/volatile free-cash-flow conversion. Valuation is a major offset (very low P/E and solid dividend yield), while technical signals are currently soft with negative momentum indicators.

Positive Factors
Improving growth and marginsRevenue growth and materially stronger gross and net margins indicate improved pricing, product mix, and cost control. If maintained, this operating improvement can support more resilient earnings, strengthen reinvestment capacity, and improve competitiveness over the next several quarters.
Negative Factors
Elevated leverageDebt remains high relative to equity despite recent improvement, increasing the company’s exposure to earnings pressure and demand weakness. Elevated leverage can restrict financial flexibility, raise the importance of stable operating performance, and limit capacity for internally funded expansion.

Cosmax BTI Inc. (044820) vs. SPDR S&P 500 ETF (SPY)

-25%0%25%50%75%100%125%KR:044820+65.79%SPY+11.79%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
KRW 209.73B
Dividend Yield
3.55%
Average Volume (3M)
38.87K
Price to Earnings (P/E)
3.8
Beta (1Y)
0.40
Revenue Growth
25.12%
EPS Growth
295.70%
Country
KR
Employees
341
Sector
General
Sector Strength
55
Industry
Packaged Foods

Cosmax BTI Inc. Business Overview & Revenue Model

Company Description

Cosmax BTI, Inc., established in 1992 and headquartered in Seongnam, South Korea, specializes in the development, manufacturing, and distribution of a diverse array of items. These include cosmetic products, dietary supplements, pharmaceutical goods,...

Cosmax BTI Inc. Financial Statement Overview

Summary

Income statement strength is the key positive (revenue up ~10.8% TTM and net margin improved to ~8.3% from much lower levels in prior years), but the overall financial picture is constrained by elevated leverage (debt/equity ~1.56x) and weak cash conversion (free cash flow ~30% of net income with noted volatility).

Income Statement

78Positive

Balance Sheet

62Positive

Cash Flow

45Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue771.33B645.21B597.63B628.60B617.40B576.00B
Gross Profit158.27B129.00B112.27B104.94B88.17B91.96B
EBITDA67.54B54.46B71.65B48.24B33.82B41.08B
Net Income63.78B29.21B16.46B9.06B-6.53B14.13B
Balance Sheet
Total Assets1.12T1.01T953.90B878.27B936.14B954.66B
Cash, Cash Equivalents and Short-Term Investments83.50B107.18B80.25B78.71B95.46B87.78B
Total Debt506.15B513.95B507.56B462.94B466.29B471.05B
Total Liabilities749.79B710.65B672.67B625.88B610.37B612.77B
Stockholders Equity324.19B275.54B251.69B231.83B300.99B308.16B
Cash Flow
Free Cash Flow15.84B4.57B2.31B2.07B16.22B-9.34B
Operating Cash Flow52.05B35.17B23.84B29.78B29.96B-22.35M
Investing Cash Flow-19.53B-12.68B-32.09B-39.01B544.38M-46.74B
Financing Cash Flow-46.67B-1.10B6.73B-7.67B-23.55B33.09B

Cosmax BTI Inc. Technical Analysis

Technical Analysis SentimentNegative
Last Price21950.00

Price Trends

50DMA23848.00Negative
100DMA21779.30Positive
200DMA18614.68Positive

Market Momentum

MACD-474.16Positive
RSI40.19Neutral
STOCH42.53Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For KR:044820, the sentiment is Negative. The current price of 21950.00 is below the 20-day moving average (MA) of 23150.00, below the 50-day MA of 23848.00, and above the 200-day MA of 18614.68, indicating a neutral trend. The MACD of -474.16 indicates Positive momentum. The RSI at 40.19 is Neutral, neither overbought nor oversold. The STOCH value of 42.53 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for KR:044820.

Cosmax BTI Inc. Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

KR:044820 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
KR:092730KR:09273082OutperformKRW 348.02B6.12―5.34%19.89%21.27%
KR:003350KR:00335077OutperformKRW 259.08B6.74―0.50%22.88%24.47%
KR:044820KR:04482065NeutralKRW 209.73B3.78―3.55%25.12%295.70%
KR:192820KR:19282060NeutralKRW 2.80T14.58―1.34%15.81%197.32%
KR:161890KR:16189056NeutralKRW 2.66T14.36―0.77%12.57%90.44%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
KR:200130KR:20013050NeutralKRW 204.92B-243.15―0.81%-8.83%-111.22%

* General Sector Average

Performance Comparison

0%50%100%KR:044820KR:003350KR:092730KR:161890KR:192820KR:200130Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
KR:044820 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
KR:044820Cosmax BTI Inc.21950.008814.8567.11%
KR:003350Hankook Cosmetics Manufacturing Co., Ltd11910.001054.319.71%
KR:092730NeoPharm Co., Ltd.22250.005900.2636.09%
KR:161890KOLMAR KOREA CO. LTD112500.0037423.8449.85%
KR:192820COSMAX, Inc.247000.0048251.7024.28%
KR:200130KolmarBNH Co., Ltd.7410.00-6179.50-45.47%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Oct 28, 2026